- 2017
-
Press releases - 24.01.2017
Personalised home care effective against Alzheimer’s disease
A new home-based therapeutic approach targeting dementia patients, “occupational therapy,” can slow their loss of autonomy and reduce behaviour problems. These results come from a new study published by Inserm researchers (Unit 1219 “Institute of Public Health, Epidemiology and Development” [ISPED]) in the Journal of Alzheimer’s Disease.
-
Press releases - 24.01.2017
Inserm, a partner in the 2nd National Day of Innovation in Health
Rétine artificielle, prothèse connectée, robot chirurgical : découvrez les derniers progrès en santé lors de la 2e Journée nationale de l’innovation en santé, à la Cité des sciences et de l’Industrie. L’Inserm sera présent lors de cet événement impulsé par le ministère de la Santé.
-
Press releases - 18.01.2017
Air pollution: alarm raised by physicians, scientists and NGOs
While the “Crit’Air” air quality sticker came into force in Paris on 16 January 2017, several physicians, scientists and NGOs launched an appeal for urgent action on air pollution, recalling that it causes 48,000 premature deaths a year in France.
-
What's on? - 18.01.2017
Air pollution: alarm raised by physicians, scientists and NGOs
While the “Crit’Air” air quality sticker came into force in Paris on 16 January 2017, several physicians, scientists and NGOs launched an appeal for urgent action on air pollution, recalling that it causes 48,000 premature deaths a year in France. While France has just endured several prolonged episodes of severe particulate pollution, leading the public […]
-
News in brief - 17.01.2017
A patient has been living with an artificial larynx for the 18 months
In 2013, researchers from Inserm and physicians from the Strasbourg University Hospitals announced their success in developing an artificial larynx. Since the first time they began implanting this prosthesis five years ago in patients whose own larynx had been removed for health reasons, they have optimized both the implant and their surgical technique. Today, they […]
-
Press releases - 14.01.2017
Ebola survivors: life afterwards
In November 2014, Inserm organised medical follow-up of people who survived infection by the Ebola virus. 802 individuals (adults and children) were included in the PostEbogui cohort. Results of follow-up show that on average one year after their initial period in hospital, 3 in 4 survivors still report health problems.
-
Press releases - 10.01.2017
Identification of one of the keys allowing entry of Zika virus into brain cells
L’équipe d’Ali Amara, directeur de recherche Inserm, décrit, dans un article publié dans Cell Reports, les mécanismes permettant au virus Zika d’infecter les cellules du système nerveux.
- 2016
-
Press releases - 21.12.2016
Potential of an immunotherapy demonstrated in the treatment of Alzheimer’s disease
The involvement of the immune system in neurological diseases suggests that immunotherapy, which has shown its effectiveness in the area of cancer and autoimmune diseases, is also of major interest in the treatment of neurodegenerative diseases. The researchers have proven that a molecule called interleukin-2 (IL-2), from the immune system, is able to control inflammation in the brain cells, which is implicated in neurodegenerative diseases such as Alzheimer’s disease, and can restore impaired cognitive functions in the animal model.
-
Press releases - 14.12.2016
Testosterone for nerve fibre repair
To protect against attack, the body uses natural repair processes.
-
Press releases - 14.12.2016
Storage of umbilical cord blood
For the first time in France, a couple has just been given authorisation to entrust a private company with the storage of umbilical cord cells from their unborn child, in view of a potential therapeutic need.